Analysis of the HLA and non-HLA susceptibility loci in Japanese type 1 diabetes

Diabetes/Metabolism Research and Reviews

Volumn 27, Issue 8, 2011, Pages 844-848

  Yamashita, Hisakuni ^a   Awata, Takuya ^a   Kawasaki, Eiji ^b   Ikegami, Hiroshi ^c   Tanaka, Shoichiro ^d   Maruyama, Taro ^e   Shimada, Akira ^f   Nakanishi, Koji ^g   Takahashi, Kazuma ^h   Kobayashi, Tetsuro ^d   Kawabata, Yumiko ^c   Miyashita, Yumi ^a   Kurihara, Susumu ^a   Morita Ohkubo, Tomoko ^a   Katayama, Shigehiro ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^c KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF YAMANASHI   (Japan)

^e Saitama Social Insurance Hospital   (Japan)

^f SAISEIKAI CENTRAL HOSPITAL   (Japan)

^g Okinaka Memorial Institute for Medical Research   (Japan)

^h IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Genetic susceptibility; Prediction model; Single nucleotide polymorphism; Type 1 diabetes

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; EPIDERMAL GROWTH FACTOR RECEPTOR 3; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 7 RECEPTOR;

ADULT; ALLELE; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HLA SYSTEM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JAPANESE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE OF ONSET; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR ANTIGENS; HLA-DRB1 CHAINS; HUMANS; INSULIN; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LECTINS, C-TYPE; MALE; MONOSACCHARIDE TRANSPORT PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; THYROID GLAND;

EID: 80855138424     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1234     Document Type: Article

References (18)

1. She JX. Susceptibility to type I diabetes: HLA-DQ and DR revisited. Immunol Today 1996; 17(7): 323-329.
2. Awata T, Kuzuya T, Matsuda A, Iwamoto Y, Kanazawa Y. Genetic analysis of HLA class II alleles and susceptibility to type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 1992; 35(5): 419-424.
3. Thomson G, Valdes AM, Noble JA, et al. Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens 2007; 70(2): 110-127.
4. Kawabata Y, Ikegami H, Awata T, et al. Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset. Diabetologia 2009; 52(12): 2513-2521.
5. Pociot F, Akolkar B, Concannon P, et al. Genetics of type 1 diabetes: what's next? Diabetes 2010; 59(7): 1561-1571.
6. Todd JA. Etiology of type 1 diabetes. Immunity 2010; 32(4): 457-467.
7. Awata T, Kawasaki E, Ikegami H, et al. Insulin gene/IDDM2 locus in Japanese type 1 diabetes: contribution of class I alleles and influence of class I subdivision in susceptibility to type 1 diabetes. J Clin Endocrinol Metab 2007; 92(5): 1791-1795.
8. Ikegami H, Awata T, Kawasaki E, et al. The association of CTLA4 polymorphism with type 1 diabetes is concentrated in patients complicated with autoimmune thyroid disease: a multicenter collaborative study in Japan. J Clin Endocrinol Metab 2006; 91(3): 1087-1092.
9. Kawasaki E, Awata T, Ikegami H, et al. Genetic association between the interleukin-2 receptor-alpha gene and mode of onset of type 1 diabetes in the Japanese population. J Clin Endocrinol Metab 2009; 94(3): 947-952.
10. Awata T, Kawasaki E, Tanaka S, et al. Association of type 1 diabetes with two loci on 12q13 and 16p13 and the influence coexisting thyroid autoimmunity in Japanese. J Clin Endocrinol Metab 2009; 94(1): 231-235.
11. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148(3): 839-843.
12. Wei Z, Wang K, Qu HQ, et al. From disease association to risk assessment: an optimistic view from genome-wide association studies on type 1 diabetes. PLoS Genet 2009; 5(10): e1000678.
13. Nielsen LB, Mortensen HB, Chiarelli F, et al. Impact of IDDM2 on disease pathogenesis and progression in children with newly diagnosed type 1 diabetes: reduced insulin antibody titres and preserved beta cell function. Diabetologia 2006; 49(1): 71-74.
14. Matejkova-Behanova M, Vankova M, Hill M, et al. Polymorphism of INS VNTR is associated with glutamic acid decarboxylase antibodies and postprandial C-peptide in patients with onset of diabetes after 35 years of age. Physiol Res 2004; 53(2): 187-190.
15. Awata T, Katsuren E, Matsumoto C, et al. Absence of shared HLA class II (DR, DQ)-linked genetic basis between IDDM and autoimmune thyroid disease in Japanese. Diabetes Care 1995; 18(4): 582-583.
16. Moriguchi M, Noso S, Kawabata Y, et al. Clinical and genetic characteristics of patients with autoimmune thyroid disease with anti-islet autoimmunity. Metabolism 2011; 60(6): 761-766.
17. Zhernakova A, van Diemen CC, Wijmenga C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet 2009; 10(1): 43-55.
18. Wang H, Jin Y, Reddy MV, et al. Genetically dependent ERBB3 expression modulates antigen presenting cell function and type 1 diabetes risk. PLoS One 2010; 5(7): e11789.